Excalibur Management Corp Amgen Inc Transaction History

Excalibur Management Corp

$261 Million
Q3 2024

A detailed history of Excalibur Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Excalibur Management Corp holds 6,406 shares of AMGN stock, worth $1.69 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

6,406

Previous 6,365 0.64%

Holding current value

$1.69 Million

Previous $1.99 Million 3.82%

% of portfolio

0.79%

Previous 0.81%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $12,684 - $13,832	41 Added 0.64%	6,406 $2.06 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $2,688 - $3,245	-10 Reduced 0.16%	6,365 $1.81 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $10,932 - $13,572	50 Added 0.79%	6,375 $1.71 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $2,142 - $2,533	10 Added 0.16%	6,325 $1.4 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $11,535 - $12,837	-50 Reduced 0.79%	6,315 $1.54 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $1,988 - $2,276	10 Added 0.16%	6,365 $1.43 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $22,191 - $25,860	100 Added 1.6%	6,355 $1.58 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $2,838 - $3,648	-15 Reduced 0.24%	6,255 $1.51 Million
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $59,764 - $69,763	-335 Reduced 5.07%	6,270 $1.22 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $1.1 Million - $1.26 Million	6,605	6,605 $1.23 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.

Account

Excalibur Management Corp Amgen Inc Transaction History